Recently, Sunpharma (one of largest Indian pharma manufacturer) was granted regulatory approval to manufacture Wegovy generic drug. With patent expiring in March 2026, will this be a threat to Novo Nordisk and if they start selling at 1/10th of Wegovy's price?